Clinical Trials

Burkitt Lymphoma, Recurrence

NCT05633615 2026-02-02

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Phase 2 Recruiting

396 enrolled

Phase 2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

NCT03642626 2026-01-23

MT2017-45: CAR-T Cell Therapy for Heme Malignancies

150 enrolled 23 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03568461 2025-10-07

ELARA

98 enrolled 9 charts 1 FDA

Phase 2 Active not recruiting

Lymphoma, Follicular, Recurrence

NCT04234061 2024-11-07

TARMAC

20 enrolled

Lymphoma, B-Cell

NCT03610724 2024-06-20

BIANCA

34 enrolled 19 charts

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT02445248 2024-04-18

JULIET

115 enrolled 22 charts 1 FDA

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02435849 2024-02-13

ELIANA

80 enrolled 39 charts

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04161118 2023-05-06

TIGER-CTL019

Phase 2 Terminated

3 enrolled

Lymphoma, Non-Hodgkin

NCT04156659 2023-03-09

Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL

Phase 2 Withdrawn

Burkitt Lymphoma

NCT04225676 2023-01-30

Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Phase 2 Terminated

5 enrolled 8 charts

Burkitt Lymphoma, Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04456023 2022-03-02

Study of Tisagenlecleucel in Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-cell Non-Hodgkin Lymphoma (DLBCL)

Phase 2 Withdrawn

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT02228096 2020-11-23

ENSIGN

75 enrolled 41 charts

Burkitt Lymphoma, Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02167360 2017-02-14

Study of Efficacy and Safety of CTL019 in Adult ALL Patients

Phase 2 Withdrawn